Fig. 8.
Survival following vaccination with 38C13 Id adenovirus with or without prior exposure to irrelevant adenovirus.
Groups of 10 mice were injected with Adβgal or PBS, vaccinated 3 weeks later with 108 PFU Ad-IdhuCR, then challenged 3 weeks later with 1000 38C13 tumor cells SQ, and followed for survival. Survival of unvaccinated PBS-treated mice is shown for comparison.P indicates comparison between Ad-IdhuCR–vaccinated mice pretreated with Adβgal or PBS. ▴ indicates PBS and Ad-IdhuCR; ● indicates Adβgal and Ad-IdhuCR; ○ indicates PBS control.
